This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Hengrui (USA) Ltd.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Kenneth H Huang: Innovator in Pharmaceutical Compounds
Introduction
Kenneth H Huang is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential applications in cancer treatment. His innovative work has led to the granting of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Kenneth H Huang holds a patent for "2-arylimidazo[1,2-B]pyridazine, 2-phenylimidazo[1,2-A]pyridine, and 2-phenylimidazo[1,2-A]pyrazine derivatives." This patent discloses compounds of formula (I), where X, Y, A, R, and other variables are defined. Additionally, the patent includes pharmaceutically acceptable salts of these compounds, compositions containing them, and methods for using these compounds to treat conditions such as cancer. His innovative approach in this area has the potential to impact therapeutic strategies significantly.
Career Highlights
Throughout his career, Kenneth H Huang has worked with prominent companies in the pharmaceutical industry, including Hengrui (USA) Ltd. and Hengrui Ltd. His experience in these organizations has allowed him to collaborate with other experts and contribute to groundbreaking research and development in the field.
Collaborations
Kenneth has collaborated with notable professionals such as Robert N Atkinson and Andy J Ommen. These partnerships have enriched his work and fostered an environment of innovation and creativity in the development of new pharmaceutical compounds.
Conclusion
Kenneth H Huang is a distinguished inventor whose work in pharmaceutical compounds demonstrates his commitment to improving healthcare outcomes. His patent and collaborations reflect his significant contributions to the field, making him a valuable asset to the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile